Monitoring cardiovascular risk factors after liver transplantation may improve outcomes
Sarah R. Lieber, Lisa B. VanWagner – 4 April 2022
Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg‐negative patients with chronic HBV infection
Danli Yang, Jun Zou, Leijie Wang, Xiangmei Chen, Fengmin Lu – 4 April 2022
Acute kidney injury after adult liver transplantation—Doesn’t intraoperative management matter?
Tetsuro Sakai – 4 April 2022
Reply
Samar H. Ibrahim, Binita M. Kamath, Kathleen M. Loomes, Saul J. Karpen – 4 April 2022
CAQ Corner: Pediatric indications for liver transplantation
Jennifer Vittorio – 3 April 2022
Identification of hepatic steatosis in living liver donors by machine learning models
Jihye Lim, Seungbong Han, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Dong Hwan Jung, Sung‐Gyu Lee, Ki‐Hun Kim, Jonggi Choi – 3 April 2022 – Selecting an optimal donor for living donor liver transplantation is crucial for the safety of both the donor and recipient, and hepatic steatosis is an important consideration. We aimed to build a prediction model with noninvasive variables to evaluate macrovesicular steatosis in potential donors by using various prediction models.
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation
Gerald Scott Winder, Jessica L. Mellinger – 3 April 2022
CAQ Corner: Genetic liver disease
James E. Squires, Simon P. Horslen – 3 April 2022
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation
Gerald Scott Winder, Jessica L. Mellinger – 3 April 2022